Medtronic Inc Product Surveillance Registry
Cary Mariash, MD
Primary Investigator
Brief description of study
The purpose of this study is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment.
Detailed description of study
The objective of the Registry is to serve as an ongoing source of acute and chronic product reliability, patient safety and clinical outcomes information associated with the use of Medtronic market-released products.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Other,Registry: Product Reliability and Patient Safety
-
Age: 100 years or below
-
Gender: All
Inclusion Criteria
Patient has or is intended to receive or be treated with an eligible Medtronic product
Patient within 30 days of therapy initiation or meets criteria for retrospective enrollment
Exclusion Criteria
Patient who is, or will be inaccessible for follow-up
Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device
tudy that may confound results
Additional Information:
